Atlas Trials

Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2)

Clinical trial NCT07375966 · RECRUITING

Trial details

NCT number
NCT07375966
Sponsor
General Hospital of Shenyang Military Region
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Ischemic Stroke
Start date
2026-03-25
Primary completion
2027-12-30
Enrollment
198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.